Literature DB >> 19495974

Prognostic significance of hERG1 expression in gastric cancer.

Xiang-Wu Ding1, Wen-Bin Yang, Shan Gao, Wei Wang, Zheng Li, Wang-Ming Hu, Jian-Jun Li, He-Sheng Luo.   

Abstract

Previous studies have demonstrated that human ether-à-go-go-related potassium channel (hERG1) is highly expressed in many tumor cell lines, as well as in primary human cancers, and, hence, have a critical role in cell cycle progress and proliferation. In this study, hERG1 expression was investigated in gastric cancer by immunohistochemistry and/or reverse transcription polymerase chain reaction (RT-PCR). It was discovered that hERG1, which was negatively expressed in surrounding non-tumor tissues, switched to aberrantly positive expression in gastric cancer. Statistically, there were significant differences in hERG1 protein expression according to factors such as serosal invasion, venous invasion, lymph node metastases, other organ metastases, and stage. The mean survival time for the hERG1-positive expression group was significantly shorter than the negative group, the survival rates for the positive group were significantly lower than the negative group, and hERG1 expression was found to be an independent prognostic factor. In summary, hERG1 channel was proved to be a potential biomarker for gastric cancer invasion and survival.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19495974     DOI: 10.1007/s10620-009-0834-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  38 in total

Review 1.  Physical and functional interaction between integrins and hERG potassium channels.

Authors:  A Arcangeli; A Becchetti; A Cherubini; O Crociani; P Defilippi; L Guasti; G Hofmann; S Pillozzi; M Olivotto; E Wanke
Journal:  Biochem Soc Trans       Date:  2004-11       Impact factor: 5.407

2.  hERG1 channels in human esophagus: evidence for their aberrant expression in the malignant progression of Barrett's esophagus.

Authors:  Elena Lastraioli; Antonio Taddei; Luca Messerini; Camilla E Comin; Mara Festini; Matteo Giannelli; Anna Tomezzoli; Milena Paglierani; Gabriele Mugnai; Giovanni De Manzoni; Paolo Bechi; Annarosa Arcangeli
Journal:  J Cell Physiol       Date:  2006-11       Impact factor: 6.384

3.  Cell cycle-dependent expression of HERG1 and HERG1B isoforms in tumor cells.

Authors:  Olivia Crociani; Leonardo Guasti; Manuela Balzi; Andrea Becchetti; Enzo Wanke; Massimo Olivotto; Randy S Wymore; Annarosa Arcangeli
Journal:  J Biol Chem       Date:  2002-11-12       Impact factor: 5.157

4.  The potent inhibitory effects of cisapride, a specific blocker for human ether-a-go-go-related gene (HERG) channel, on gastric cancer cells.

Authors:  Xiao-Dong Shao; Kai-Chun Wu; Zhi-Ming Hao; Liu Hong; Jing Zhang; Dai-Ming Fan
Journal:  Cancer Biol Ther       Date:  2005-03-20       Impact factor: 4.742

5.  A HERG-like K+ channel in rat F-11 DRG cell line: pharmacological identification and biophysical characterization.

Authors:  L Faravelli; A Arcangeli; M Olivotto; E Wanke
Journal:  J Physiol       Date:  1996-10-01       Impact factor: 5.182

6.  Quantification of the completeness of follow-up.

Authors:  Taane G Clark; Douglas G Altman; Bianca L De Stavola
Journal:  Lancet       Date:  2002-04-13       Impact factor: 79.321

7.  HERG K(+) currents in human prolactin-secreting adenoma cells.

Authors:  C K Bauer; I Wulfsen; R Schäfer; G Glassmeier; S Wimmers; J Flitsch; D K Lüdecke; J R Schwarz
Journal:  Pflugers Arch       Date:  2002-12-06       Impact factor: 3.657

8.  VEGFR-1 (FLT-1), beta1 integrin, and hERG K+ channel for a macromolecular signaling complex in acute myeloid leukemia: role in cell migration and clinical outcome.

Authors:  Serena Pillozzi; Maria Felice Brizzi; Pietro Antonio Bernabei; Benedetta Bartolozzi; Roberto Caporale; Venere Basile; Vieri Boddi; Luigi Pegoraro; Andrea Becchetti; Annarosa Arcangeli
Journal:  Blood       Date:  2007-04-09       Impact factor: 22.113

9.  Human ether-a-go-go-related gene 1 channels are physically linked to beta1 integrins and modulate adhesion-dependent signaling.

Authors:  Alessia Cherubini; Giovanna Hofmann; Serena Pillozzi; Leonardo Guasti; Olivia Crociani; Emanuele Cilia; Paola Di Stefano; Simona Degani; Manuela Balzi; Massimo Olivotto; Enzo Wanke; Andrea Becchetti; Paola Defilippi; Randy Wymore; Annarosa Arcangeli
Journal:  Mol Biol Cell       Date:  2005-03-30       Impact factor: 4.138

10.  HERG potassium channels are more frequently expressed in human endometrial cancer as compared to non-cancerous endometrium.

Authors:  A Cherubini; G L Taddei; O Crociani; M Paglierani; A M Buccoliero; L Fontana; I Noci; P Borri; E Borrani; M Giachi; A Becchetti; B Rosati; E Wanke; M Olivotto; A Arcangeli
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

View more
  14 in total

1.  Imatinib has the potential to exert its antileukemia effects by down-regulating hERG1 K+ channels in chronic myelogenous leukemia.

Authors:  Fang Zheng; Huiyu Li; Kaiwei Liang; Yimei Du; Dongmei Guo; Shiang Huang
Journal:  Med Oncol       Date:  2011-12-10       Impact factor: 3.064

Review 2.  Cellular physiological approach for treatment of gastric cancer.

Authors:  Atsushi Shiozaki; Daisuke Ichikawa; Eigo Otsuji; Yoshinori Marunaka
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

Review 3.  The roles of K(+) channels in cancer.

Authors:  Luis A Pardo; Walter Stühmer
Journal:  Nat Rev Cancer       Date:  2013-12-12       Impact factor: 60.716

Review 4.  Potential prognostic, diagnostic and therapeutic markers for human gastric cancer.

Authors:  Ming-Ming Tsai; Chia-Siu Wang; Chung-Ying Tsai; Hsiang-Cheng Chi; Yi-Hsin Tseng; Kwang-Huei Lin
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

5.  Kir2.1 Interaction with Stk38 Promotes Invasion and Metastasis of Human Gastric Cancer by Enhancing MEKK2-MEK1/2-ERK1/2 Signaling.

Authors:  Cheng-Dong Ji; Yan-Xia Wang; Dong-Fang Xiang; Qiang Liu; Zhi-Hua Zhou; Feng Qian; Lang Yang; Yong Ren; Wei Cui; Sen-Lin Xu; Xi-Long Zhao; Xia Zhang; Yan Wang; Peng Zhang; Ji-Ming Wang; You-Hong Cui; Xiu-Wu Bian
Journal:  Cancer Res       Date:  2018-03-16       Impact factor: 12.701

6.  Immunohistochemical biomarkers in gastric cancer research and management.

Authors:  Elena Lastraioli; Maria Raffaella Romoli; Annarosa Arcangeli
Journal:  Int J Surg Oncol       Date:  2012-06-24

Review 7.  Ion channels or aquaporins as novel molecular targets in gastric cancer.

Authors:  Jianling Xia; Hongqiang Wang; Shi Li; Qinghui Wu; Li Sun; Hongxiang Huang; Ming Zeng
Journal:  Mol Cancer       Date:  2017-03-06       Impact factor: 27.401

Review 8.  hERG1 Potassium Channels: Novel Biomarkers in Human Solid Cancers.

Authors:  Elena Lastraioli; Tiziano Lottini; Lapo Bencini; Marco Bernini; Annarosa Arcangeli
Journal:  Biomed Res Int       Date:  2015-08-03       Impact factor: 3.411

9.  Atrial natriuretic peptide modulates the proliferation of human gastric cancer cells via KCNQ1 expression.

Authors:  Jia Zhang; Zhilong Zhao; Chao Zu; Haijian Hu; Hui Shen; Mingxin Zhang; Jiansheng Wang
Journal:  Oncol Lett       Date:  2013-06-25       Impact factor: 2.967

Review 10.  Potassium channels in cell cycle and cell proliferation.

Authors:  Diana Urrego; Adam P Tomczak; Farrah Zahed; Walter Stühmer; Luis A Pardo
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-02-03       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.